Clinical trial
Safety Study of Albuterol Spiromax® in Subjects With Asthma
NCT01698320
Study timeline
Study start (unknown)2012-10-01Date precision: month
Registry last updated2015-08-19
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Asthmaunresolved
Interventions
Placebo MDPIDRUG
Albuterol MDPIDRUG
Sponsors & collaborators
Teva Branded Pharmaceutical Products R&D, Inc.lead sponsor
Mapped research locations
MiamiFlorida, United States2San AntonioTexas, United States2DenverColorado, United States2St LouisMissouri, United States1SeattleWashington, United States1CincinnatiOhio, United States1San DiegoCalifornia, United States1PortlandOregon, United States1MinneapolisMinnesota, United States1RochesterNew York, United States1BethesdaMaryland, United States1LouisvilleKentucky, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01698320 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.